The addition of cryptotanshinone, a well-characterized inhibitor of STAT3, to the cells treated by sclareol enhanced the inhibitory effect of sclareol and confirmed that the effects of sclareol on breast cancer cells are mediated through JAK/STAT pathway. This evidence concerns the gene STAT3 and breast carcinoma.